Piao Y - Search Results

1

Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.

Lucio-Eterovic AK, Piao Y, de Groot JF. Lucio-Eterovic AK, et al. Among authors: piao y. Clin Cancer Res. 2009 Jul 15;15(14):4589-99. doi: 10.1158/1078-0432.CCR-09-0575. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567589

2

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.

de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, Conrad CA. de Groot JF, et al. Among authors: piao y. Neuro Oncol. 2010 Mar;12(3):233-42. doi: 10.1093/neuonc/nop027. Epub 2010 Jan 6. Neuro Oncol. 2010. PMID: 20167811 Free PMC article.

3

Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.

de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV. de Groot JF, et al. Among authors: piao y. Clin Cancer Res. 2011 Jul 15;17(14):4872-81. doi: 10.1158/1078-0432.CCR-11-0271. Epub 2011 Jun 1. Clin Cancer Res. 2011. PMID: 21632852 Free PMC article. Clinical Trial.

4

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.

Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF. Piao Y, et al. Neuro Oncol. 2012 Nov;14(11):1379-92. doi: 10.1093/neuonc/nos158. Epub 2012 Sep 10. Neuro Oncol. 2012. PMID: 22965162 Free PMC article.

5

Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.

de Groot J, Liang J, Kong LY, Wei J, Piao Y, Fuller G, Qiao W, Heimberger AB. de Groot J, et al. Among authors: piao y. Oncotarget. 2012 Sep;3(9):1036-48. doi: 10.18632/oncotarget.663. Oncotarget. 2012. PMID: 23013619 Free PMC article.

6

Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.

Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF. Piao Y, et al. Clin Cancer Res. 2013 Aug 15;19(16):4392-403. doi: 10.1158/1078-0432.CCR-12-1557. Epub 2013 Jun 26. Clin Cancer Res. 2013. PMID: 23804423

7

Neutrophils promote the malignant glioma phenotype through S100A4.

Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, de Groot JF. Liang J, et al. Among authors: piao y. Clin Cancer Res. 2014 Jan 1;20(1):187-98. doi: 10.1158/1078-0432.CCR-13-1279. Epub 2013 Nov 15. Clin Cancer Res. 2014. PMID: 24240114 Free PMC article.

8

Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy.

Liang J, Piao Y, Henry V, Tiao N, de Groot JF. Liang J, et al. Among authors: piao y. Oncotarget. 2015 Oct 13;6(31):31479-92. doi: 10.18632/oncotarget.5491. Oncotarget. 2015. PMID: 26362401 Free PMC article.

9

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

Piao Y, Park SY, Henry V, Smith BD, Tiao N, Flynn DL, de Groot JF. Piao Y, et al. Neuro Oncol. 2016 Sep;18(9):1230-41. doi: 10.1093/neuonc/now030. Epub 2016 Mar 9. Neuro Oncol. 2016. PMID: 26965451 Free PMC article.

10

Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.

Park SY, Piao Y, Jeong KJ, Dong J, de Groot JF. Park SY, et al. Among authors: piao y. Mol Cancer Ther. 2016 Sep;15(9):2187-97. doi: 10.1158/1535-7163.MCT-15-0427. Epub 2016 Jun 15. Mol Cancer Ther. 2016. PMID: 27307601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

981 results

Search Page